Tiger Brokers

HK StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

GENSCRIPT BIO

14.500
-0.040-0.28%
Volume:18.86M
Turnover:272.87M
Market Cap:31.60B
PE:1.32
High:14.660
Open:14.560
Low:14.260
Close:14.540
Loading ...
OverviewCompanyNewsFilings

Company Profile

Company Name:
GENSCRIPT BIO
Exchange:
SEHK
Establishment Date:
2002
Employees:
5568
Office Location:
Jiangning Science Park,No. 28, Yongxi Road,Jiangning District,Nanjing,Jiangsu Province,China
Website:
http://www.genscript.com
Zip Code:
211100
Phone:
86 25 5889 7288
Fax:
- -
Introduction:
Genscript Biotech Corp is a company primarily engaged in bioscience research and related businesses. The Company operates through four segments. The Life-Science Services and Products segment provides comprehensive reagent services and products, instruments and custom-tailored solutions for gene therapy, cell therapy, antibody therapeutics, vaccines and diagnostics. The Biologics Development Services segment provides comprehensive services aimed to help biopharmaceutical and biotech companies accelerate the development of therapeutic antibodies, and gene/cell therapy products with an integrated platform. The Industrial Synthetic Biology Products segment provides industrial enzyme development and production by non-pathogenic microbial strains constructed using genetic engineering. The Cell Therapy segment is engaged in the discovery and development of novel cell therapies for oncology and other indications.

Directors

Name
Position
MENG Jian Ge
Chairman of the Board,Executive Director,Chairman of the Nomination Committee
WANG Ye
Executive Director,Member of the Remuneration and Assessment Committee,Member of the Nomination Committee
ZHU Li
Executive Director
ZHANG Fang Liang
Executive Director,Chairman of the Strategic and Development Committee,风险管理和环境、社会及管治委员会主席
PAN Jiu An
Independent Director,Member of the Strategic and Development Committee,Member of the Nomination Committee,Audit Committee Member,风险管理和环境、社会及管治委员会委员
ZHANG Yao Liang
Independent Director,Member of the Nomination Committee,Audit Committee Chairman,风险管理和环境、社会及管治委员会委员
SHI Chen Yang
Independent Director,Member of the Strategic and Development Committee,Chairman of the Remuneration and Assessment Committee,Member of the Nomination Committee
Alphonse Galdes
Independent Director,Audit Committee Member
John Anthony Quelch
Independent Director,Member of the Strategic and Development Committee
Ross Allen Grossman
Independent Director,Member of the Remuneration and Assessment Committee
WEI Shi Niu
制裁风险控制委员会委员
SHAO Wei Hui
制裁风险控制委员会委员

Shareholders

Name
Position
WANG Ye
General Manager
WEI Shi Niu
CFO
SHAO Wei Hui
COO,Other Senior Executives
HUANG Hui Ling
Corporate Secretary
ZHU Li
Other Senior Executives